Introduction
The human ocular surface spans from the conjunctiva to the cornea and plays a critical role in visual perception. Cornea, the anterior portion of the eye, is transparent and provides the eye with two-thirds of its focusing power and protection of ocular integrity. The cornea consists of five main layers, namely, corneal epithelium, Bowman's layer, corneal stroma, Descemet's membrane and corneal endothelium. The outermost layer of the cornea, which is exposed to the external environment, is the corneal epithelium. Corneal epithelial integrity and transparency are maintained by somatic stem cells (SC) that reside in the limbus. The limbus, an anatomical structure 1-2 mm wide, circumscribes the peripheral cornea and separates it from the conjunctiva (Cotsarelis et al., 1989, Davanger and Evensen, 1971) (Figure 1) . Any damage to the ocular surface by burns, or various infections, can threaten vision. The most insidious of such damaging conditions is limbal stem cell deficiency (LSCD) . Clinical signs of LSCD include corneal vascularization, chronic stromal inflammation, ingrowth of conjunctival epithelium onto the corneal surface and persistent epithelial defects (Lavker et al., 2004) . Primary limbal stem cell deficiency is associated with aniridia and ectodermal dysplasia. Acquired limbal stem cell deficiency has been associated with inflammatory conditions (Stevens-Johnson syndrome (SJS), ocular cicatricial pemphigoid), ocular trauma (chemical and thermal burns), contact lens wear, corneal infection, neoplasia, peripheral ulcerative corneal disease and neurotrophic keratopathy (Dua et al., 2000 , Jeng et al., 2011 . Corneal stem cells and/or their niche are known to play important anti-angiogenic and anti-inflamatory roles in maintaining a normal corneal microenvironment, the destruction of which in LSCD, tips the balance toward pro-angiogenic conditions (Lim et al., 2009) . For a long time, the primary treatment for LSCD has been transplantation of healthykeratolimbal tissue from autologous, allogenic, or cadaveric sources. In the late 1990s, cultured, autologous, limbal epithelial cell implants were used successfully to improve vision in two patients with chemical injury-induced LSCD (Pellegrini et al., 1997) . Since then, transplantation of cultivated epithelial (stem) cells has become a treatment of choice for numerous LSCD patients worldwide. While the outcomes are promising, the variability of methodologies used to expand the cells, points to an underlying need for better standardization of ex vivo cultivation-based therapies and their outcome measures , Ti et al., 2004 , Grueterich et al., 2002b , Kolli et al., 2010 . This chapter provides a general update on LSCD pathogenesis, the key role of stem cells and their niche in maintaining corneal homeostasis and avascularity and a general update on LSCD pathogenesis. An overview of different methodologies used for ex vivo stem cell expansion will shed some light on the future of cell-based therapy for LSCD patients.
What defines limbal stem cell niche
The ocular surface is anatomically composed of the entire epithelial surface of the cornea, limbus and conjunctiva, and is physically continuous with the eyelids and adenexa. The limbal epithelium, which separates the corneal epithelium from the conjunctival epithelium, is made up of a nonkeratinizing, stratified squamous epithelium, which is much thicker, up to 10 cell layers, than the central corneal epithelium. Moreover, limbal epithelium is thought to contain the source of the stem cells (SC) that serve as the source of corneal epithelial cell the corneal limbal stem cells are depleted below a certain threshold, the cornea becomes covered by an abnormal conjunctiva-like epithelium, a process termed "conjunctivalization." As a result of LSC deficiency, neovascularization, chronic inflammation, recurrent erosions, ulceration and stromal scarring can occur, causing painful vision loss (Holland and Schwartz, 1996, Kenyon and Tseng, 1989) . LSCD is classified as either primary or secondary. Primary LSCD is characterized by the absence of identifiable external factors and an insufficient microenvironment to support the LSCs. Primary LCSD is seen in hereditary aniridia, congenital erythrokeratoderma, keratitis with multiple endocrine deficiencies and inadequate nutrition or cytokine supply, neurotrophic keratopathy, peripheral inflammation, and sclerocornea (Puangsricharern and Tseng, 1995) . Dysfunction/poor regulation of stromal microenvironment of limbal epithelial SCs results in gradual loss of the SC population or TAC generation and amplification. Secondary LSCD occurs following the destruction of LSCs by external factors such as trauma, chemical-acid or alkali or thermal injuries (Tseng, 1985) , or ultraviolet and ionizing radiation (Fujishima et al., 1996) ; systemic conditions such as Stevens-Johnson Syndrome (SJS), or ocular cicatricial pemphigoid (OCP) (Pfister, 1994) .
Clinical conditions
The corneal epithelium cannot be maintained or renewed in eyes with LSCD, and leads to chronic epithelial defects. As the condition progresses, punctate epithelial keratopathy may develop and lead to severe epithelial defect. Due to decreased healing ability, corneal epithelial defects may become persistent, which can lead to stromal scarring, ulceration, and perforation (Puangsricharern and Tseng, 1995) . Conjunctivalization of the cornea may occur, where the corneal epithelium is replaced with a conjunctival epithelial phenotype (Huang and Tseng, 1991) . Loose intercellular connections result in stippled or late staining with fluorescein, and a lack of normal hemidesmosomal attachments at the base of corneal epithelial cells (Dua and Forrester, 1990) . The cause of the LSCD often dictates whether the disease is unilateral or bilateral (i.e., affecting one eye or both).
Pathology of limbal stem cell deficiency and histologic, ultrastructural studies
Currently, diagnosis of LSCD is based on clinical evaluation, although clinical signs and symptoms of LSCD are nonspecific and common to several ocular surface diseases. The disease manifests as epithelial defects, chronic inflammation, keratitis, vascularization, and fibrosis, ultimately resulting in corneal blindness. In the absence of specific markers for limbal stem cells, identification of conjunctival goblet cells on the corneal surface is used to demonstrate conjunctival epithelial ingrowth or growth of epithelia on the corneal surface and to confirm the diagnosis of LSCD (Tseng, 1989 , Dua and Forrester, 1990 , Pfister, 1994 . Normal limbal architecture, with rows of palisades and a perilimbal vascular arcade, is usually best defined at the superior and inferior limbus. Definition of the palisades is less distinct nasally and temporally. Delicate changes such as staining of conjunctiva-derived cells on and across the limbus, which may be associated with a persistent epithelial defect, and other changes such as scarring, vascularization, or limbal hyperaemia, indicating chronic inflammation, can be seen in the early stages. SC deficiency following mild injury, a superficial or a disease process is slowly progressive, and loss of a segment of limbal epithelium may occur without significant damage to the substratum. A sheet of conjunctival/metaplastic epithelium without any notable vascularization consequently covers the cornea (Dua, 1998) . Other pathological conditions resulting from LSCD are abnormal conjunctival/metaplastic epithelium; tags of loose epithelium filaments with mucus, and recurrent erosions, with unstable tear film that readily takes up fluorescein dye (Huang and Tseng, 1991) . In moderate to severe cases of SC deficiency, superficial and/or deep vascularization of the cornea occurs. Initially it is restricted to the segment with SC deficiency, but in later stages, the entire circumference may become involved. However, in moderate to severe cases of SC deficiency, epithelial cover of the denuded cornea is associated with encroachment of fibrovascular tissue of varying thicknesses (Kenyon and Tseng, 1989) . In human eyes, ocular surface insult from chemical burns may go beyond damage to the limbal tissue, leading to long-term ocular surface damage. This damage may include distortion and dysfunction of proximal or distal bulbar conjunctiva, tarsal conjunctiva, and anterior orbital tissues, resulting in abnormalities in surface mucous secretion and wetting, cicatrizing of conjunctiva, symblepharon, and entropion (McCulley, 1990 , McCulley et al., 1983 , Grant and Kern, 1955 . In summary, alkali burns are the commonest cause of severe LSCD, producing longstanding and persistent changes, like epithelial hyperplasia, fibrosis, and inflammation of the ocular surface. Presence of goblet cells on the cornea confirms the diagnosis of LSCD, but their absence does not rule it out, and correlates presence or absence with prolonged interval and squamous metaplasia of the entire surface in such cases (Fatima et al., 2008) .
Accompanying neovascularization
The cornea is avascular, but a wide variety of insults can cause capillary invasion from the limbal vascular plexus. This process of new blood vessel formation is termed as corneal neovascularization (NV) (Chang et al., 2001 , Takahashi et al., 1999 . The three major categories of corneal NV are superficial vascularization, fibrovascular pannus, and deep stromal vascularization. Superficial vascularization rarely causes a decrease in vision; however, the latter two types of corneal NV can lead to significant loss of vision if they involve the visual axis. The most frequent causes of corneal angiogenesis are injury and defective limbal stem cells.
Putative mechanisms of LSCD and corneal neovascularization
There is a delicate balance between angiogenic and anti-angiogenic factors in the cornea, which determines its vascularity or lack thereof. The normal cornea is avascular, and corneal epithelial stem cells may play a significant role in maintaining the angiogenic balance in favour of avascularity. Nevertheless, there are numerous pro-angiogenic factors that play key roles in pathologic corneal NV. A comprehensive review of all the factors was described by Lim et.al, and included key factors and their possible mechanisms of action (Lim et al., 2009) .
Angiogenic factors and anti-angiogenic factors
Vascular endothelial growth factor (VEGF) is a protein that acts as a mitogen for vascular endothelial cells, stimulating these cells to divide and multiply. The most important member of this group is VEGF-A, which has been shown to stimulate endothelial cell proliferation and migration. It also increases microvascular permeability. In rats with surgically induced LSCD, high levels of VEGF correlated with inflammation and corneal NV. The corneal NV was suppressed with the addition of anti-VEGF antibody (Amano et al., 1998) . Other members of this family include VEGF-B, VEGF-C, VEGF-D, and placenta growth factor. Inflammatory cytokines, chemokines, and cell adhesion molecules (CAMs) play a significant role in inflammatory cell infiltration and angiogenesis. The inflammatory cytokine interleukin-1 (IL-1) interacts directly with endothelial cells to stimulate migration and proliferation. IL-6 can stimulate corneal and inflammatory cells, in a paracrine manner, to secrete VEGF (Biswas et al., 2006) . Tumor necrosis factor- (TNF-) enhances leukocyte infiltration (Yoshida et al., 1997) . Chemokines are a family of secreted proteins that act as chemoattractants for inflammatory cells through activation of chemokine receptors. They may also enhance endothelial cell chemotaxis and proliferation (Berger et al., 1999) . The chemokines IL-8 (Strieter et al., 1992 , Koch et al., 1992 and monocyte chemoattractant-1 (MCP-1) (Goede et al., 1999) have been shown to induce corneal NV in rabbit corneas. Cell adhesion molecules (CAMs) are proteins located on the cell surface involved in binding with other cells or with the extracellular matrix. They facilitate inflammatory cell infiltration into the corneal stroma by mediating the rolling, adhesion, or trans-endothelial migration of leukocytes (Vaporciyan et al., 1993) . Fibroblast growth factors (FGF) are a family of heparinbinding peptides that are expressed in tissues during angiogenesis, cellular differentiation, mitogenesis, and wound repair. Basic fibroblast growth factor (bFGF) is an angiogenic factor that exhibits differential binding of vascular basement membranes in newly formed corneal vessels, based on degree of maturation of the vessels (Soubrane et al., 1990) . Several anti-angiogenic factors are produced by corneal epithelial cells, and a variety of vascular endothelial cell inhibitors including angiostatin, endostatin, restin, neostatin, and thrombospondins. Several of these endogenous anti-angiogenic factors are derived from the proteolysis of larger extracellular matrix proteins that have no intrinsic anti-angiogenic activity. Angiostatin, for example, is derived from the proteolysis of plasminogen. Endostatin is another example, produced by the cleavage of collagen XVIII. It inhibits proliferation (Hanai et al., 2002) and migration of endothelial cells (EC), and induces EC apoptosis. It may block the activation and catalytic activity of matrix metalloproteinases (MMPs) and interfere with the binding of VEGF to its receptors. Arrestin, canstatin, and tumstatin, derived from collagen IV, also inhibit the proliferation and migration of ECs and induce EC apoptosis. Restin, which is related to endostatin, is produced by the proteolytic cleavage of collagen XV and is believed to inhibit EC migration . Neostatin, derived from collagen XVIII, and thrombospondin are other inhibitors of EC proliferation. Avascular tissue-derived factors, such as pigment epithelium-derived factor (PEDF), and angiogenic factor antagonists, such as angiopoetin-2, have been found in the cornea (Karakousis et al., 2001) . PEDF and angiopoetin-2 inhibit angiogenesis by inhibiting endothelial cell migration and inducing EC apoptosis.
Role of matrix metalloproteinases (MMPs)
Matrix metalloproteinases (MMPs) are a family of zinc-dependent proteases. They are commonly categorized as collagenases, gelatinases, matrilysins, or membrane-type MMPs, and they play a role in the proteolytic processes involved in angiogenesis (Chang et al., 2001) . Their action is inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs). Some are involved in the cleavage process that generates the anti-angiogenic factors angiostatin and endostatin. Plasminogen activator inhibitors inhibit tissue plasminogen activator (tPA) and urokinase plasminogen activator (uPA), the activators of plasminogen, thereby preventing fibrinolysis and the physiologic breakdown of blood clots. In response to corneal injury, lipid mediators are released from cell membranes. Platelet activating factor (PAF) is a lipid mediator that facilitates endothelial cell migration through the cornea via increased expression of VEGF (Tao et al., 1996) , MMP-9 (Tao et al., 1995) , and uPA (Tao et al., 1996) . Another important lipid mediator is 12(R)-HETrE, an arachidonic acid metabolite that binds to limbal endothelial cells and causes endothelial mitogenesis and neovascularization (Stoltz and Schwartzman, 1997) .
Animal disease models
Development of experimental animal models to study ocular NV have been useful in understanding its mechanisms and pathogenesis, as well as to developing potential therapeutic modalities. For example, this basic research led to the discovery of new therapeutic targets for pathologic ocular NV (Barouch and Miller, 2006) . In the field of neovascular research, the testing of angiogenic and anti-angiogenic substances relies heavily on the sensitivity and specificity of in vivo and ex vivo bioassays. Several corneal angiogenesis models in the rabbit have been described, including direct intrastromal injections of substances like heparin-copper complex (Alessandri et al., 1983) , induced chemical or thermal injury (Deutsch and Hughes, 1979, Korey et al., 1977) , and intrastromal tumor implantation (Gimbrone et al., 1974) . The cornea suture model created in mice and rabbits simulate a clinical scenario and are not expensive. However, models inducing an inflammatory component have disadvantages that are surgery dependent and yield highly variable responses. Recently developed micropocket assay models are not expensive, less time consuming; however, they are surgery dependent and yield highly variable responses (Rogers et al., 2007 , Loughman et al., 1996 . A conjunctivalized corneal epithelium lacks the smoothness and cohesion of normal corneal epithelium, making it optically inferior and prone to erosions. It is also heavily vascularized. To study inflammatory response, an important component of NV, Moromizato et al. produced burn and chemical cornea model lesions by corneal cauterization or local injection into the cornea of small amounts of acid (hydrochloric acid, 0.1 N) or alkali (sodium hydroxide, 0.1 N) (Moromizato et al., 2000) . Complex pathophysiology is a disadvantage of this model. Animal models will continue to be needed for evaluation of safety and efficacy of combination therapies (Kim et al., 2006) . Each model has strengths and weaknesses; thus, in order to gain the most useful information about the disease process and responses to therapy, the best approach may be combination of different models. Therefore, search for better, more reliable and reproducible animal models should continue.
Treatment modalities
be performed. This prevents conjunctival epithelium from crossing the limbus and allows the corneal epithelium to heal the defect. A groundbreaking report by Kenyon and Tseng, describes case studies where autologous limbal stem cell transplantation proved to be a powerful and effective surgical procedure to restore severely damaged ocular surfaces (Kenyon and Tseng, 1989) . However, in later studies, where donor tissue was harvested in a "blinded" fashion, two surgical risks were identified. First, if the donor limbal grafts do not contain adequate numbers of stem cells, the surgery will either fail immediately or lack longevity. Second, if too many stem cells are removed, the donor eye will develop problems associated with LSCD (Copeland and Char, 1990 , Holland and Schwartz, 1996 , Holland, 1996 , Frucht-Pery et al., 1998 .
Amniotic membrane transplantation
Human amniotic membrane (HAM) has several properties that render it extremely useful as a biomaterial for surgical purposes and it promotes epithelialization, inhibits fibrosis, has anti-inflammatory, anti-angiogenic, antimicrobial and antiviral properties, and has a high hydraulic conductivity (van Herendael et al., 1978 , Fernandes et al., 2005 Moreover, HAM shows low or no immunogenicity (Akle et al., 1985 , Akle et al., 1981 . Over the past decade, HAM's abilities to reduce scarring and inflammation, and enhance wound healing, as well as its epithelialization properties, has led to an increase in its use as a biomaterial in ophthalmic surgery, particularly for ocular surface reconstruction. HAM has also been used to promote healing in corneal diseases such as chemical and thermal burns, neurotrophic ulcers, persistent epithelial defects, shield ulcers, microbial keratitis, band keratopathy and bullous keratopathy (Dua et al., 2004 , Tosi et al., 2005a , Tosi et al., 2005b . Furthermore, the use of HAM as a biomaterial has not been confined to ophthalmologyit is also widely used in general surgery and wound treatment, e.g., for burned skin, bedsores, ulcers (Faulk et al., 1980) , and in head and neck surgery (Zohar et al., 1987) . More recently, HAM has been used as a culture substrate for ex vivo cultured LSC transplantation.
Corneal limbal autografts and allografts
The current treatment for LSCD is limbal transplantation using auto-or allograft limbal tissues, each of which have their associated risks and benefits. In 1989, Kenyon and Tseng, treated LSCD by transplanting healthy limbal tissue on diseased limbus, procedure termed as conjunctival limbal autograft (CLAU) and living-related conjunctival limbal autograft (lr-CLAL) (Kenyon and Tseng, 1989) . The main disadvantage of taking limbal tissue from the patient's own contralateral healthy eye or from that of a living related donor is the risk of inducing LSCD in the donor eye, if a large amount of tissue is required (Jenkins et al., 1993) . In bilateral cases with total LSCD, or in a one-eyed patient who develops total LSCD in the seeing eye, an allograft limbal transplant utilizing donor tissue from a cadaver or a living relative is the only option. A high risk of immune rejection is associated with such transplantation because of the vascularity of the limbus, the high immunogenic stimulus of the limbal transplant relative to the abundance of Langerhan's cells and HLA-DR antigens. Hence, an effective immunosuppressant is essential indefinitely or until the graft is viable. Moreover, the dosage of immunosuppression can be increased or decreased if it proves ineffective or causes adverse effects, respectively (Tseng et al., 1998 , Coster et al., 1995 . For this reason, transplantation of auto-or allograft limbal tissues is not often a viable treatment option.
Ex vivo expansion of corneal limbal stem cells
A novel method of transplanting limbal stem cells is ex vivo expansion of LSCs. This technique is based on Rheinwald and Green's pioneering work in skin (Green et al., 1977) . Skin epithelial cells have been grown successfully on a feeder layer of 3T3 fibroblasts that have been rendered mitotically inactive by irradiation or treatment with mitomycin C (Rheinwald, 1980) . In the late 1990s, cultured autologous limbal epithelial cells were successfully used to improve vision in two patients with chemical injury-induced LSCD. From 1-2 mm 2 limbal tissue, epithelial cells were isolated and expanded in the laboratory on tissue culture plastic, in the presence of growth-arrested 3T3 mouse fibroblast feeders, before transfer to the eye on a petrolatum gauze or a soft contact lens (Pellegrini et al., 1997) . This technique has theoretical advantages over conventional treatments. Its proposed advantage over CLAU and lr-CLAL is that the required size of the limbal biopsy is substantially smaller. This minimizes the risk of precipitating stem cell failure in the donor eye and provides the option of taking a further biopsy if required. Since 1997's landmark report, a variety of culture techniques have been developed to produce contiguous epithelial cell sheets for transplantation. These techniques can be broadly defined as either explant culture in which cells migrate out from limbal tissue attached to a surface (Grueterich et al., 2002b , Koizumi et al., 2001a , Koizumi et al., 2001b , Sangwan et al., 2006 or suspension culture in which cells are released from enzymatically digested extracellular matrix before culture (Daya et al., 2005 , Pellegrini et al., 1997 . The aforementioned methods have been used in studies to culture limbal epithelial cells successfully, on either a growth-arrested 3T3 fibroblast feeder layer or an amniotic membrane (AM), with varying results (Kim et al., 2004 , Zito-Abbad et al., 2006 .
Explant culture method
The explant culture method involves plating a whole piece of limbal tissue or limbal explant, sized approximately 1 mm by 1 mm. One variation of the explant culture system uses AM, which acts as both a substrate and a carrier for the cultured cells. To attain growth from limbal explants the limbal biopsy is placed on the basement membrane surface of the amniotic membrane and allowed to adhere to it. Once attached, the biopsy and amniotic membrane are submerged in culture medium (Figure 3) . This contains nutrients and mitogens that stimulate LSCs to proliferate and migrate out of the biopsy and cover the surface of the AM, which occurs over a period of 14 to 28 days. Recently, exciting discussions have led to the question of whether or not AM epithelial cells are necessary to cultivate limbal epithelial cells. Several groups have cultured limbal epithelial cells on intact AM (AM with amniotic epithelium) and have reported that these limbal epithelial cells contained slow-cycling and label-retaining characteristic cells, which did not express corneal epithelial differentiation proteins cytokeratin 3 (CK3) or cytokeratin 12 (CK12) and connexin 43. The amniotic epithelial cells were killed by cryopreservation and then removed by enzymatic digestion, chemical treatment, or physical scraping of the membrane prior to use (Koizumi et al., 2001a , Koizumi et al., 2001b , Nakamura et al., 2004b . Grueterich et al. demonstrated that culturing LSC on amnion with intact amniotic epithelium may result in a more stem cell-like phenotype than with deepithelialized amnion (Grueterich et al., 2002b) . Their study showed that, while cells on both the substrates were well attached to the AM stroma, morphologically superior, better stratified and/or differentiated limbal cells could be cultured on denuded AM compared to those cells cultured on intact AM. As a result, these studies hypothesized that denuded AM is probably a more practical carrier for human limbal epithelial cell cultures in a cellsuspension culture system. Kolli et al. analyzed the outgrowths from human cadaveric limbal explants cultured on AM by dividing the explant outgrowths into three zonesinner, middle, and outer, depending on proximity to the explant. This yielded a successive decline in colony-forming efficiency (CFE), and ΔNp63 and ABCG2 expression, and an increase in expression of CK3 in zones further away from the explants. These Results support the importance of putative niche environment in maintaining the undifferentiated state of the limbal stem cells during explant outgrowth (Kolli et al., 2008) .
Suspension culture system
The cell suspension culture system employs the enzymes dispase, which digests basement membrane collagen and separates epithelial cells from the stroma, and trypsin, which separates clumps of limbal epithelial cells into a suspension of single cells (Figure 4) . The single cells are then seeded either onto AM or onto a plastic tissue culture dish containing a feeder layer of growth-arrested 3T3 fibroblasts. Culture medium is then added, and the cells are incubated for 14 to 21 days. When confluent, the epithelial sheet is transferred to the ocular surface using either a contact lens or fibrin gel (Pellegrini et al., 1997, Pellegrini et 
1999). Recently, Di Girolamo et al. cultured limbal epithelial cells in autologous serum, on lotrafilcon A and balafilcon A contact lenses.
The cells cultured on the lotrafilcon A contact lenses proliferated, migrated, showed a corneal phenotype and microvillae on the apical surface; whereas cells cultured on balafilcon A contact lenses showed no growth (Di Girolamo et al., 2007) . Various substrates have been used in suspension culture systems for proliferation of limbal epithelial cells, for example, reconstituted collagen substrate membrane from HAM (Merrett et al., 2008 ), a chitosan cross-linked collagen membrane (Auxenfans et al., 2009 ), which has good adherence, retains epithelial morphology and supports the nontoxic nature of the membrane. Reconstituted human amniotic collagen membrane has been used to act as collagen scaffolding for the culture of limbal epithelial cells (Doillon et al., 2003 , Griffith et al., 1999 , Li et al., 2005 . Rama et al. have provided data demonstratng that the use of fibrin as a carrier supports stem cell maintenance (Rama et al., 2001) .
Variations in explant and suspension cultures
The variations in explant and cell suspension culture systems are airlifting and/or (with or without the addition) of 3T3 feeder cells. In airlifting cultures, the level of culture medium in the dish is lowered to the surface level of the epithelium, promoting stratification and differentiation of the epithelium (Ban et al., 2003 , Cooper et al., 2004 , Koizumi et al., 2001a , Nakamura et al., 2003b . This method can, therefore, be used for investigating the stratification and differentiation potential of cultured limbal epithelial cells with high expression of CK3 and CK12. The latter culture method, adding 3T3 feeder cells as an additional feeder layer of growth-arrested 3T3 fibroblasts in the bottom of the cell culture well is a duplex system (Miyashita et al., 2008) . 3T3 fibroblasts are primitive cells isolated from embryonic mice. They have a high proliferative capacity and have been used extensively in the culture of epithelial stem cells especially in skin and cornea. Both amniotic membrane and growth-arrested 3T3 fibroblasts inhibit the differentiation of corneal epithelial cells ex vivo, which allows the expansion of the population of LSCs (Grueterich et al., 2003 , Pellegrini et al., 1999 . Denuded AM is thought to be an excellent substrate for the corneal limbal cell culture used for ocular surface reconstruction, even though AM epithelial cells contain various growth factors with 3T3 feeder cells. This theory, however, remains to be fully investigated. The variation in suspension culture techniques are use of novel temperature-responsive culture surfaces. Temperature-responsive polymers chemically immobilized to thin films on cell-culture surfaces facilitate cell adhesion and growth of cells in normal culture conditions, at 37°C. Temperatures below 30°C can reversibly alter cell hydration properties with respect to temperature, hydration and swellingprompting complete detachment of adherent cells without the use of proteolytic enzymes or treatment with EDTA (Nishida et al., 2004b , Nishida et al., 2004a . The advantage of this system is that no enzymes are needed to free the epithelial sheet from the culture membrane; however, application of temperature-responsive polymers in a clinical setting remains questionable for safety and efficacy.
Ex vivo expansion of alternative sources of epithelium
Although adult stem cells hold considerable promise for the treatment of a number of diseases in regenerative medicine, the second major obstacle has been to obtain sufficient number of autologous or allogeneic stem cells.
Oral mucosal cells
In an attempt to overcome the problems inherent in the transplantation of allogeneic tissue, there has been recent interest in the possibility of using alternative autologous epithelial cells. There are several potential sources of non-keratinizing, stratified squamous epithelium in the adult human, including oral mucosal, conjunctival, nasal, esophageal, vaginal and rectal epithelia. The main concept is to use the smooth surface of the oral mucosa, with its stem cell properties, to reconstruct the ocular surface. Oral mucosae are thought to be at a lower stage of differentiation than epidermal keratinocytes (Collin et al., 1992 , Schermer et al., 1986 because they divide rapidly and can be maintained in culture for prolonged periods without keratinization (Hata et al., 1995) . Various antimicrobial peptides (AMPs) are known to be present on the epithelial cells of ocular and oral surfaces (Haynes et al., 1999) . Moreover, keratin 3 is expressed by both corneal epithelium (Sangwan et al., 2003b) and oral mucosa (Collin et al., 1992 , Juhl et al., 1989 , suggesting that gene expression in oral and corneal epithelium may be similar. Wet-surfaced epithelia, produce a group of highly glycosylated, protective membrane glycoproteins termed mucins (Gipson, 2007) . Although the function of these mucins in the oral cavity remains to be elucidated, it is possible that they contribute to the epithelial protective mucin layer and act as receptors initiating one or more intracellular signal transduction pathways (Argueso et al., 2003) . At the ocular surface, at least three membrane-associated mucins (MUC1, -4, and -16) and two secreted mucins (MUC5 and -7) are expressed (Hori et al., 2007) . More extensive studies have been performed to check the feasibility of using cultivated oral mucosal epithelium (COME) for this purpose, as it is readily available and could be harvested without invasive surgery. A small biopsy of the patient's oral mucosa is harvested, connective tissue is dissected and, after enzymatic digestion, an epithelial cell suspension is prepared. The oral epithelial cells are cultivated on the substrate with a feeder layer. The sheet of cultivated cells is then transplanted onto the diseased ocular surface (Figure 5) . These studies suggest that oral mucosal epithelium is a feasible alternative for Fig. 5 . Systematic representation of cultivated oral mucosal epithelium transplantation. Adopted from (Lim et al., 2009) . allogenous limbal transplants (Nakamura et al., 2003b , Nakamura et al., 2004a , Nishida et al., 2004b , Hayashida et al., 2005 . Oral mucosal epithelium cultured on human amniotic membrane with the help of feeder cells has been characterized extensively, and has been used to reconstruct the ocular surface in rabbits (Nakamura et al., 2003a) as well as humans with chemical injury and SJS (Nakamura et al., 2004a) . In the lengthiest study reported so far, cultured oral mucosal epithelial cells were transplanted into patients with LSCD and followed up with for up to 34 months where the followups continued until tissue became viable. The main advantages of using oral mucosa are the absence of tissue rejection and, therefore, avoidance of immunosuppression; easy access to the oral cavity; inconspicuous location of the resultant small scar, and repeatability. This treatment method has not, however, provided satisfactory long-term results. The oral mucosal epithelial cell grafts seldom transdifferentiate to a corneal epithelium phenotype, e.g., expression of keratin 12 (Krt12) . This new approach, however, provides an exciting possibility for treatment of this difficult group of patients with blindness from bilateral total LSCD and warrants further study.
Dental pulp stem cells
In an attempt to prevent rejection, isolated human immature dental pulp stem cells (hIDPSC) from deciduous teeth have been used as an autologous alternative epithelium source for LSCD treatment or corneal reconstruction. hIDPSCs are known to express both mesenchymal stem cell markers (SH2, SH3 and SH4) and human embryonic stem cell markers (OCT 4, NANOG, SSEA-3 and SSEA-4) (Gomes et al., 2010) . Furthermore, hIDPSCs have a normal karyotype and show the capacity for multilineage differentiation into neurons, smooth and skeletal muscle, cartilage, bone, and other cell types ex vivo and in vivo (Kerkis et al., 2006 , Lavagnolli et al., 2009 ). Limited studies have been performed to test dental pulp stem cells as potential treatment for LSCD. Monteiro et al. demonstrated, using immunohistochemistry and reverse transcription polymerase chain reaction, that hIDPSCs express markers in common with LSCs, such as ABCG2, integrin 1, vimentin, p63, connexin 43 and cytokeratins 3/12. These have been shown to be capable of reconstructing the eye surface after induction of unilateral total LSCD in rabbits (Monteiro et al., 2009) . Further studies are required to understand the long-term outcome of LSCD treated using hIDPSCs.
Hair follicle stem cells
Hair has the potential to regenerate from stem cells located at the lower part of the follicle called the bulge (Oshima et al., 2001) . Additionally, hair follicle stem cells (HFSCs) can give rise to epidermis and sebaceous gland tissues. Recently, Blazejewska et al. demonstrated that murine HFSCs can transform into epithelia-like cells when cultured in limbal fibroblastderived medium (Blazejewska et al., 2009) . Although, these findings need further substantiation using in vivo functional studies in animal models, they provide the first step towards the design of protocols that could use human autologous hair follicle stem cells to replace corneal epithelium in therapeutic applications. Due to their multipotency, easy accessibility, and high proliferation rate ex vivo, hair follicles are an attractive source of autologous adult stem cells and a promising therapeutic tool for ocular surface reconstruction.
Embryonic stem cells
Embryonic stem cells (ESCs) are pluripotent (i.e., they can give rise to any cell type in the body) and are derived from the inner cell mass of a blastocyst. Differentiation of ESCs to a corneal epithelial lineage could be achieved by replication of the LSC niche environment. Transplantation of epithelial cells derived from mouse ESCs have been used to reconstruct chemically injured mouse corneas (Homma et al., 2004) . Moreover, human ESCs express cornea-like epithelial markers such as CK3 and CK12 when cultured in conditions similar to those of the limbal stem cell niche. Ex vivo replication of the LSC niche environment has been achieved by culturing hESCs on an extracellular matrix of collagen IV and fed with medium conditioned with limbal fibroblasts (Ahmad et al., 2007) . The differentiated human ESCs demonstrate phenotypic differences to cultured human limbal epithelial cells, such as differences in size and cilia length, which are characteristically much longer than those of limbal epithelial cells. These data suggest that some differences exist between LSCs and hESCderived corneal progenitors (Ahmad et al., 2007) . The translation of this approach to human therapeutic use requires further work to overcome problems associated with functionality, complete hESC differentiation and immune rejection as well as ethical concerns.
Future considerations for cultivated epithelial transplants
Ex vivo expansion of limbal epithelium has been performed by several unrelated groups in a number of countries and used to treat a variety of ocular surface disorders that are thought to be the result of limbal stem cell failure. Despite a substantial number of experimental models of this technique and an ever-growing body of laboratory data on limbal epithelial stem cell biology, scientific basis for this procedure is poorly understood. Future considerations in the field of limbal epithelial cell culture and transplantation methods are discussed below.
Culture methodologies
The culture of limbal epithelium is essential for furthering our understanding of limbal stem cell biology. Ex vivo expansion of LSCs for the treatment of LSCD is one of the more recent stem cell treatments available in the field of regenerative medicine. Although the technique of ex vivo expansion of LSCs is still in its infancy, it is starting to be used by several groups for clinical purposes, and different approaches have been attempted. There are many varying techniques for culturing limbal epithelial cells, such as different media and sera; culture with 3T3 fibroblasts or amniotic membrane, or both; removal of amniotic membrane epithelial cells from the membrane, or not; use of explant or suspension methods; and airlifting of the culture, or not (Shortt et al., 2007 , Grueterich et al., 2003 . Whichever culture method is used, the end result, often after a period of weeks, is a cultivated epithelial sheet composed of LSCs. The ease of explanting culture technique could be adapted without initial dispase treatment for transplantation studies. However, further studies on the interaction between epithelial progenitor and autologous stromal cells ex vivo, and complete characterization of limbal cells in this culture system, including cell junction proteins, are required.
Autologous sources and xenobiotic-free conditions
With growing concerns regarding the potential transmission of opportunistic agents such as prions and animal viruses, it would be preferable to culture cells for human transplantation under xenobiotic-free conditions. In limbal corneal epithelial cultures, the use of autologous human serum in the medium and/or human amniotic membrane would be appropriate as it would reduce the need for animal cells or products in the culture (Kolli et al., 2010 , Nakamura et al., 2004a . To avoid contamination from xeno-feeder layers, different human feeder layers have also been developed and analyzed (Chen et al., 2007) . Moreover, cells have been cultured on feeder layers during the proliferative phase and further separated using robotic technology (Schneider et al., 2008) . Limbal epithelial cells grown with MRC-5 human embryonic fibroblasts can sustain the stem cell phenotype (Notara et al., 2007) . The successful use of autologous serum-derived oral epithelial equivalent to treat severe ocular surface disease was reported in 2006 (Ang et al., 2006 . This represents an important advance in the pursuit of completely autologous xenobiotic-free bioengineered ocular equivalents for clinical transplantation.
In conclusion, a specific culture system that mimics natural tissue architecture and its niche closely by enabling formation of an autofeeder layer, thereby eliminating the need for xenofeeder layers for ex vivo expansion of epithelial progenitor cells is important.
Combination techniques with anti-angiogenic treatments
Angiogenic and anti-angiogenic cytokines are involved in cell migration and differentiation in wound healing and tumor progression (even in the absence of angiogenesis). The everincreasing use of anti-angiogenic therapy for corneal neovascularization brings great promise for the treatment of a wide variety of corneal conditions, including LSCD. TGF-, IL-1, and VEGF are the key pro-angiogenic factors involved in the process of angiogenesis; and are targets for anti-angiogenic therapies. The ultimate goal for research on corneal angiogenesis is to discover effective treatment for pathological corneal neovascularization; however, to date, most anti-angiogenic therapies remain experimental. Angiostatin, a 38 kDa proteolytic fragment of plasminogen, is a potent anti-angiogenic factor. Recombinant angiostatin has been used successfully to suppress tumor growth and metastasis in animal model systems (Shin et al., 2000 , Ambati et al., 2002 . Gabison and associates have demonstrated the involvement of angiostatin in corneal avascularity after wounding. They confirmed that angiostatin-like molecules are expressed in the corneal epithelium and in cultured corneal epithelial cells (Gabison et al., 2004) . Corneal neovascularization was observed after excimer laser keratectomy when anti-angiostatin antibodies were injected into the cornea; this was significantly higher than when plasmin B chain antibodies were injected. These studies suggest that angiostatin may contribute to the maintenance of corneal avascularity after excimer laser keratectomy. The corneal epithelium may be the source of anti-angiogenic molecules. It has long been demonstrated that corneal epithelium inhibits angiogenesis (Kaminski and Kaminska, 1978) . Ferreras and associates demonstrated the generation of endostatin-like fragments by cleaving collagen XVIII with MMP-2, -3, -9, -12, -13, or -14 (Ferreras et al., 2000) . Upregulation of matrix-derived anti-angiogenic factors such as endostatin (Kato et al., 2003) and restin (Saika et al., 2004) , along with increased anti-inflammatory factor IL-1ra may play an important role in LSC and AM transplantation-mediated anti-angiogenic effect. Recently, Cursiefen et al. demonstrated a critical mechanism that contributed to corneal avascularity by VEGF receptor 3, which is normally present on lymphatic and proliferating blood vascular endothelium, is strongly constitutively expressed by corneal epithelium and is mechanistically responsible for suppressing inflammatory corneal angiogenesis (Cursiefen et al., 2006) . Knowledge gained from using epithelia-matrix interaction to regulate corneal angiogenesis will enable us to optimize the anti-angiogenic effect of the cultivated cells like oral mucosal epithelial cells or mesehchymal stem cells for future ocular surface reconstruction.
Clinical trials and outcomes: present and future
LSCD by any cause may result in poor corneal epithelialization, persistent epithelial defects, corneal vascularization, corneal scarring, and so-called conjunctivalization of the cornea. These problems may in turn lead to decreased vision, ocular discomfort and pain, as well as an unstable ocular surface. Limbal stem cells may be partially or totally depleted, resulting in varying degrees of stem cell deficiency and resulting abnormalities on the corneal surface. The first use of ex vivo expanded LSCs for the treatment of LSCD in human subjects was described by Pellegrini and co-workers, who used a culture system of LSCs grown on mouse J2-3T3 fibroblasts with fetal calf serum (FCS) supplemented media (Pellegrini et al., 1997) . Since then, several studies have been reported on the transplantation of ex vivo cultured LSCs to treat LSCD (Schwab et al., 2000 , Tsai et al., 2000 , Koizumi et al., 2001b , Grueterich et al., 2002a . Schwab et al. reported the results of treating 19 eyes of 18 patients (Schwab, 1999) . In 2003, Sangwan et al. reported the largest study to date, which enrolled 125 patients (Sangwan et al., 2003b) . In this study ex vivo cultured limbal and conjunctival epithelial cells were grown on AM. In 2006, Sangwan et al. published a more detailed report on clinical outcomes for 88 eyes of 86 patients (Sangwan et al., 2006) . In 2001, Rama et al. reported treatment outcomes for 18 eyes of 18 patients (Rama et al., 2001) . The same group recently reported a 10 year follow-up with permanent restoration of transparent corneal epithelium in 76.6% of eyes, with few 63 instances of inflammation out of 113 eyes treated (Rama et al., 2010) . The outcome of cultured limbal stem cells transplants differed significantly depending on whether the transplanted cultures contained more than 3% p63-bright holoclone-forming stem cells or 3% or less -the success rates were 78% with the larger number of stem cells and 11% increase with the smaller number of p63 cells (Rama et al., 2001 , Rama et al., 2010 , suggesting the importance of a high percentage of p63 in cultured limbal stem cells. The remaining studies each treated between 2 and 14 patients (Kolli et al., 2010 , Grueterich et al., 2002b , Nakamura et al., 2004a , Sangwan et al., 2003a . In total, current studies reported data to enable analysis of outcomes in 506 eyes (Baylis et al., 2011) treated using ex vivo, cultured LSC transplants and 27 eyes treated with ex vivo cultured oral mucosal epithelium. To date, the limited periods (mean follow-up was 16.74 months, median 14 months, range 6 to 29.5 months), the use of subjective outcome measures, and the absence of a reliable method for detecting transplanted (stem) cells shows that a long term success rate has yet to be established. Ex vivo expansion and transplantation of limbal epithelium have been performed by several unrelated groups in a number of countries, with uncertainty in the limbal stem cell cultivation, with different variables, including source of donor limbal tissue, culture method (e.g., suspension versus explant culture), culture composition (e.g., 3T3 fibroblasts, amniotic membrane and fibrin), and variation in culture time. Overall the success rate for cultured limbal epithelial transplantation is 76%. This is based on clinical restoration of the corneal epithelium. It is interesting that, despite the different methodologies employed, the success rates and number of significant clinical outcomes are remarkably high. It would, therefore, appear that, as long as viable limbal epithelial stem cells are transferred, the method used to achieve this is relatively unimportant.
The future directions in LSC transplantation involve modifications of existing technologies to allow improved safety and efficacy of techniques at hand. The studies on the molecular mechanism of limbal stem cells and their niche will enhance our knowledge of how cell therapy can be further modified to closely mimic in vivo conditions. Identification of key niche factors controlling limbal stem cell behaviour would allow these conditions to replicate ex vivo and, thus, make the process of culturing limbal stem cells safer and more efficient. Newly developed transplantation techniques using tissue-engineered epidermal adult stem cells, immature dental pulp stem cells (Gomes et al., 2010) , and hair follicle bulgederived stem cells (Blazejewska et al., 2009) were reportedly successful for the reconstruction of corneal epithelium in an animal model of severe LSCD. The recombinant human crosslinked collagen scaffold and a Food and Drug Administration-approved contact lens are also promising new techniques for successfully achieving ocular surface reconstruction (Di Girolamo et al., 2007) . There are main challenges in improving the established techniques, in elimination of animal-derived products and minimization of allogeneic human tissue use. Since cell-based therapies are being scrutinized by ever-increasing regulatory requirements, many investigators that have been successfully performing ex vivo cultivation in the past are reformulating their methodologies to conform to these guidelines (Daniels et al., 2006 , Kolli et al., 2010 . The future of this methodology lies in the standardization of the stem cell preparation and cultivation techniques with clearly defined endpoints and outcome measures of treatment success.
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